ClinVar Miner

Submissions for variant NM_016213.5(TRIP4):c.336_339del (p.Gln113fs)

dbSNP: rs1900263561
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Revvity Omics, Revvity RCV001785089 SCV002022432 pathogenic not provided 2020-03-31 criteria provided, single submitter clinical testing
Neuberg Centre For Genomic Medicine, NCGM RCV003389340 SCV004101470 likely pathogenic Spinal muscular atrophy with congenital bone fractures 1 criteria provided, single submitter clinical testing The frameshift deletion p.Q113Kfs*30 in TRIP4 (NM_016213.5) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Q113Kfs*30 variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation caused a frameshift mutation. The frame shifted sequence continues 30 residues until a stop codon is reached. The p.Q113Kfs*30 variant is a loss of function variant in the gene TRIP4, which is intolerant of Loss of Function variants. For these reasons, this variant has been classified as Likely Pathogenic. The observed variant was also detected in the spouse.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.